CJC-1295 (No DAC) vs Alpha-Klotho: Mechanism, Half-Life & Research Use

Direct Comparison: CJC-1295 (No DAC) vs Alpha-Klotho

CJC-1295 (No DAC) is a 29-amino acid growth hormone-releasing hormone (GHRH) analog that stimulates pulsatile growth hormone secretion via the GHRH receptor. Conversely, Alpha-Klotho is a single-pass transmembrane or soluble protein that functions as a essential co-receptor for fibroblast growth factor 23 (FGF23) and regulates phosphate homeostasis. They serve fundamentally distinct biochemical targets in preclinical research models.

While both compounds are investigated in models of tissue homeostasis and metabolic regulation, CJC-1295 (No DAC)—frequently referenced as Modified GRF (1-29)—operates primarily along the somatotropic axis. In contrast, Alpha-Klotho operates as an anti-aging protein involved in oxidative stress mitigation, mineral regulation, and Wnt pathway modulation. Researchers evaluating these compounds must align their experimental designs with the appropriate physiological receptor target.

Technical Criteria & Specification Overview

To assist laboratory personnel in selecting the appropriate reagent for in vitro assays or animal models, the core physical, chemical, and biological properties of CJC-1295 (No DAC) and Alpha-Klotho are detailed in the comparative matrix below.

| Criteria | CJC-1295 (No DAC) | Alpha-Klotho | | :--- | :--- | :--- | | **Primary Receptor Target** | Growth Hormone-Releasing Hormone Receptor (GHRHR) | FGF Receptor 1c (FGFR1c) / Klotho Complex | | **Mechanistic Class** | Synthetic GHRH Secretagogue Analog | Anti-Aging Co-Receptor / Humoral Factor | | **Reported Half-Life** | ~30 minutes (In Vivo Rodent) | ~7 hours (Soluble Isoform) | | **Primary Solubility** | Water / Bacteriostatic Water | Aqueous Buffers (PBS, pH 7.2–7.4) | | **Typical Preclinical Model** | Pituitary Secretion & Tissue Repair | Wnt Signaling, Aging & Renal Models | | **Standard Vial Sizes** | 2 mg, 5 mg | 100 mcg, 1 mg |

Laboratory researchers can review our complete catalog of all peptides to analyze purity specifications, lot-specific batch records, and chemical characteristics prior to experimental design.

Molecular Structure and Receptor Targeting

CJC-1295 (No DAC) is a synthetic modification of human GHRH (1-29) containing four amino acid substitutions (D-Ala2, Gln8, Ala15, and Leu27). These modifications confer enhanced enzymatic resistance against dipeptidyl peptidase-IV (DPP-IV) cleavage while maintaining affinity for the GHRH receptor located on anterior pituitary somatotrophs. By binding to this G-protein coupled receptor (GPCR), it activates the adenylate cyclase pathway, elevating intracellular cyclic AMP (cAMP) and driving pulsatile endogenous GH release.

Alpha-Klotho, by comparison, is a much larger polypeptide existing as a single-pass transmembrane protein or a shed soluble protein (s-Klotho). It contains two internal repeat domains (KL1 and KL2) with homology to family 1 beta-glucosidases. Alpha-Klotho forms a functional complex with fibroblast growth factor receptors (FGFRs, specifically FGFR1c), greatly increasing their binding affinity for circulating FGF23. This activation initiates downstream intracellular cascades involved in phosphate excretion, vitamin D metabolism, and inhibition of insulin/IGF-1 signaling pathways associated with cellular longevity.

CJC-1295 (No DAC) Mechanism: GHRH Signaling Pathway

In preclinical settings, CJC-1295 (No DAC) serves as a classic GHRH analog. Studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research, it mimics native hypothalamic GHRH without inducing continuous, non-physiological baseline elevation. The lack of a Drug Affinity Complex (DAC) moiety ensures that the compound does not irreversibly bind serum albumin, permitting rapid systemic clearance and preserving physiological GH pulsatility.

When introduced to somatotroph cultures or rodent test models, CJC-1295 (No DAC) triggers a rapid influx of extracellular calcium via voltage-gated channels, culminating in exocytosis of pre-stored growth hormone granules. Downstream, elevated serum GH acts upon hepatic receptors to stimulate insulin-like growth factor 1 (IGF-1) synthesis. In laboratory models, this mechanism is frequently evaluated in studies focusing on skeletal muscle repair, nitrogen retention, collagen synthesis, and lipid oxidation.

Alpha-Klotho Mechanism: Longevity and Enzymatic Pathways

The physiological role of Alpha-Klotho extends across multiple organ systems, making it a pivotal subject in biogerontology and metabolic research. In its membrane-bound form, Alpha-Klotho functions obligately with FGFR1c to bind bone-derived FGF23, suppressing NaPi-2a transporters in renal proximal tubules to inhibit phosphate reabsorption. This mechanism is critical in research examining hyperphosphatemia and vascular calcification.

In its soluble form, Alpha-Klotho acts as an endocrine or paracrine factor. In vitro data indicate that soluble Klotho possesses weak beta-glucuronidase activity and directly interacts with cell-surface receptors to inhibit Wnt signaling, transform growth factor-beta 1 (TGF-beta1) signaling, and insulin/IGF-1 pathway hyperactivation. Through these interactions, Alpha-Klotho suppresses reactive oxygen species (ROS) accumulation and promotes cellular resistance to oxidative stress in culture models.

Comparative Pharmacokinetics and Half-Life Dynamics

The pharmacokinetic profile of CJC-1295 (No DAC) is characterized by a short half-life of approximately 30 minutes in rodent models. This rapid clearance profile is intentionally leveraged in experimental protocols designed to mimic natural, episodic bursts of growth hormone. Because it lacks the albumin-binding maleimide group found in CJC-1295 DAC, it does not accumulate in systemic circulation over multi-day treatment protocols.

In contrast, recombinant or soluble Alpha-Klotho demonstrates a longer circulating half-life, reported around 7 hours in rodent plasma assays. This extended presence reflects its function as a regulatory enzyme and circulating humoral factor. While CJC-1295 (No DAC) requires precise timing relative to sampling points in acute release assays, Alpha-Klotho protocols often monitor chronic downstream transcription changes, systemic mineral balances, and markers of senolytic activity over extended incubation or dosing schedules.

Comparative Analysis with Related Secretagogues

When mapping out secretagogue and metabolic research, investigator teams often evaluate multiple compounds within the same functional family. For instance, CJC-1295 (No DAC) is frequently compared with other GHRH analogs such as sermorelin, as well as ghrelin receptor agonists like ipamorelin. Combining a GHRH analog with a selective growth hormone secretagogue receptor (GHSR) agonist is a common experimental model used to evaluate synergistic GH release in vitro.

Conversely, Alpha-Klotho sits in a distinct class of longevity proteins alongside factors like FGF21 and Sirtuin activators, which do not stimulate direct pituitary GH exocytosis. Understanding these mechanistic boundaries prevents cross-contamination of experimental variables, ensuring that pathways regulating acute tissue regeneration (somatotropic) are not confused with broad systemic anti-aging cascades (Klotho/FGF23).

Study Design Selection: Matching Compounds to Objectives

Selecting between CJC-1295 (No DAC) and Alpha-Klotho depends entirely on the primary end-point of the research project. For investigations focused on somatotroph receptor kinetics, acute muscle protein synthesis, bone density accrual, or localized wound healing, CJC-1295 (No DAC) provides a highly targeted GHRH-mediated model. Its quick onset and moderate duration of action allow precise control over GH pulse amplitude.

For studies targeting longevity biomarkers, renal function, suppression of vascular calcification, or age-associated cognitive decline models, Alpha-Klotho is the superior candidate. Researchers studying cellular senescence, stem cell pluripotency retention, and oxidative stress resistance benefit from Alpha-Klotho's broad modulation of Wnt and growth factor pathways. Additional reference material on structuring secretagogue assays can be found in our comprehensive research hub.

Reconstitution, Handling, and Laboratory Storage

Proper reconstitution and storage procedures are critical to maintaining peptide integrity and obtaining reproducible experimental data. CJC-1295 (No DAC) is typically supplied as a lyophilized powder and should be reconstituted using sterile bacteriostatic water or standard laboratory-grade sterile saline. Researchers can utilize our online reconstitution calculator to accurately determine solvent volumes and resulting concentration parameters.

Alpha-Klotho, being a significantly larger protein complex, requires delicate handling. It should be reconstituted in sterile aqueous buffers such as Phosphate-Buffered Saline (PBS, pH 7.2–7.4), avoiding high-shear vortexing which can denature secondary structures. Both compounds should be aliquoted after reconstitution and stored at -20°C or -80°C to prevent degradation through repeated freeze-thaw cycles. All procedures must strictly adhere to laboratory safety standards for research compounds intended for in vitro or animal models.

Quality Assurance: HPLC, Mass Spectrometry, and Endotoxin Standards

To guarantee valid scientific outcomes, laboratory reagents must adhere to strict analytical metrics. Every lot of peptide produced for PX1 Research undergoes rigorous testing in ISO 17025 accredited facilities. High-Performance Liquid Chromatography (HPLC) verifies chemical purity (consistently exceeding 98%), while Mass Spectrometry (MS) confirms exact molecular weight and sequence identity.

In addition, endotoxin testing (LAL assay) is conducted to ensure compounds are suitable for sensitive cell culture and animal tissue models without triggering non-specific inflammatory signaling. Researchers can access batch-specific documentation directly through our dedicated COA verification page. Bulk research facilities and academic institutions requiring custom quantities or dedicated batch reservations can coordinate through our wholesale service portal.